GENETIC SIGNATURES LIMITED - Announcements

Market Cap $131.4M Add to my watchlist

Technology Scientific & Technical Instruments

Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx)... Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx) company. The Company’s principal activities include research and commercialization of identifying individual genetic signatures to identify diseases and the sale of associated products into the diagnostic and research marketplaces. The Company is focused on the development and commercialization of its platform technology, 3base. Its MDx 3base platform technology provides high-volume hospitals and pathology laboratories with the ability to screen for an array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment. It designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen brand. Its products include EasyScreen Pan-Enteric Detection Kit, EasyScreen STI Genital Pathogen Detection, EasyScreen Viral Meningitis Detection Kit and others. More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) is stepping up its trial activities in Australia’s nearest Asian neighbour, Indonesia. Recce’s flagship anti-infective, R327, can be applied as a gel – and this gel-based version of the drug has been of specific interest...

Announcements

Filter Results

All Price Sensitive Only

GSS	Final Director's Interest Notice		30/04/24	220.2KB	Share
GSS	Leadership Transition at Genetic Signatures	PRICE SENSITIVE	30/04/24	572.05KB	Share
GSS	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/04/24	336.36KB	Share
GSS	TGA authorises supply of updated Respiratory Detection Kit	PRICE SENSITIVE	22/04/24	393.22KB	Share
GSS	Becoming a substantial holder		12/03/24	88.12KB	Share
GSS	Change of Director's Interest Notice		29/02/24	221.02KB	Share
GSS	1H 24 Market Update	PRICE SENSITIVE	22/02/24	1.96MB	Share
GSS	Half Yearly Report and Accounts	PRICE SENSITIVE	22/02/24	624KB	Share
GSS	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	340.82KB	Share
GSS	Change in substantial holding		29/01/24	135.89KB	Share
GSS	Change of Director's Interest Notice - S Chatonsky		25/01/24	221.4KB	Share
GSS	Change of Director's Interest Notice - C Waldron		25/01/24	220.68KB	Share
GSS	Change of Director's Interest Notice - T Radford		25/01/24	220.84KB	Share
GSS	Change of Director's Interest Notice - J Melki		25/01/24	220.89KB	Share
GSS	Change of Director's Interest Notice - N Samaras		25/01/24	225.71KB	Share
GSS	Application for quotation of securities - GSS		25/01/24	24.53KB	Share
GSS	Successful completion of underwritten rights issue		24/01/24	416.29KB	Share
GSS	Change in substantial holding		22/01/24	139.58KB	Share
GSS	Change in substantial holding		03/01/24	688.78KB	Share
GSS	Change in substantial holding		03/01/24	3.26MB	Share
GSS	Change in substantial holding		02/01/24	212.97KB	Share
GSS	Rights Issue - Additional Payment Option For NZ Shareholders		02/01/24	206.25KB	Share
GSS	Rights Issue - Notification to Ineligible Shareholders		02/01/24	679.52KB	Share
GSS	Genetic Signatures Rights Issue Offer Booklet	PRICE SENSITIVE	02/01/24	6.48MB	Share
GSS	Change of Director's Interest Notice		29/12/23	227.6KB	Share
GSS	Notification of cessation of securities - GSS		29/12/23	21.6KB	Share
GSS	Notification regarding unquoted securities - GSS		29/12/23	25.64KB	Share
GSS	Cleansing Notice		29/12/23	265.5KB	Share
GSS	Application for quotation of securities - GSS		29/12/23	24.88KB	Share
GSS	Genetic Signatures Successfully Completes Placement	PRICE SENSITIVE	29/12/23	390.16KB	Share
GSS	Cleansing Notice		21/12/23	576.15KB	Share
GSS	Proposed issue of securities - GSS		21/12/23	38.11KB	Share
GSS	Capital Raising Presentation	PRICE SENSITIVE	21/12/23	3.97MB	Share
GSS	Genetic Signatures Announces $15.9m Capital Raising	PRICE SENSITIVE	21/12/23	919.66KB	Share
GSS	$6.9m R&D tax incentive received	PRICE SENSITIVE	19/12/23	205.32KB	Share
GSS	Trading Halt	PRICE SENSITIVE	19/12/23	221.87KB	Share
GSS	Initial Director's Interest Notice		04/12/23	190.68KB	Share
GSS	Genetic Signatures Appoints Non-Executive Director		04/12/23	347.88KB	Share
GSS	AGM Results of Meeting		29/11/23	75.63KB	Share
GSS	2023 AGM Chairman's Address and CEO Presentation	PRICE SENSITIVE	29/11/23	2.72MB	Share
GSS	Quarterly update and Appendix 4C	PRICE SENSITIVE	30/10/23	341.45KB	Share
GSS	2023 Notice of Annual General Meeting/Proxy Form		27/10/23	2.9MB	Share
GSS	Investor Presentation - US Commercial Launch		19/09/23	8.04MB	Share
GSS	Change in substantial holding		15/09/23	882.67KB	Share
GSS	Investor Webinar - FY2023 Results and US FDA 510(k)		04/09/23	168.29KB	Share
GSS	510(k) Filing in Preparation for US Commercial Launch	PRICE SENSITIVE	04/09/23	2.52MB	Share
GSS	FDA 510(k) for Gastrointestinal Parasite Kit Submitted	PRICE SENSITIVE	04/09/23	231.67KB	Share
GSS	Appendix 4G and Corporate Governance Statement		31/08/23	483.66KB	Share
GSS	Appendix 4E and Annual Report	PRICE SENSITIVE	31/08/23	4.19MB	Share
GSS	Influenza B Detection Expected to Impact on Quarter Sales	PRICE SENSITIVE	25/08/23	284.96KB	Share
GSS	Quarterly update and Appendix 4C	PRICE SENSITIVE	31/07/23	345.68KB	Share
GSS	CFO/Company Secretary Appointment		16/06/23	52.78KB	Share
GSS	Quarterly update and Appendix 4C	PRICE SENSITIVE	28/04/23	1.16MB	Share
GSS	Company Secretary/CFO Appointment/Resignation		21/03/23	130.9KB	Share
GSS	Investor Presentation		14/03/23	3.07MB	Share
GSS	Change of Director's Interest Notice		01/03/23	263.79KB	Share
GSS	Half Yearly Report and Accounts	PRICE SENSITIVE	22/02/23	1.36MB	Share
GSS	Investor presentation		02/02/23	2.37MB	Share
GSS	Quarterly update and Appendix 4C	PRICE SENSITIVE	30/01/23	286.28KB	Share
GSS	Notification of cessation of securities - GSS		11/01/23	22.11KB	Share
GSS	Investor webinar presentation		09/12/22	3.43MB	Share
GSS	Change of Director's Interest Notice		18/11/22	260.76KB	Share
GSS	Notification regarding unquoted securities - GSS		18/11/22	25.09KB	Share
GSS	Results of Meeting		16/11/22	177.49KB	Share
GSS	Chairman's Address to Shareholders & CEO Presentation		16/11/22	3.86MB	Share
GSS	Change of Registry Address		31/10/22	77.61KB	Share
GSS	Notification regarding unquoted securities - GSS		27/10/22	27.74KB	Share
GSS	Notification of cessation of securities - GSS		27/10/22	21.59KB	Share
GSS	Application for quotation of securities - GSS		27/10/22	24.83KB	Share
GSS	Quarterly update and Appendix 4C	PRICE SENSITIVE	27/10/22	250.52KB	Share
GSS	Investor presentation		18/10/22	5.59MB	Share
GSS	Notice of Annual General Meeting/Proxy Form		14/10/22	475.48KB	Share
GSS	Response to ASX Query	PRICE SENSITIVE	03/10/22	505.94KB	Share
GSS	Appendix 4G and Corporate Governance Statement		30/09/22	592.67KB	Share
GSS	Annual Report to shareholders		30/09/22	4.39MB	Share
GSS	3base Kit for Antimicrobial Resistance Shows High Detection	PRICE SENSITIVE	29/09/22	132.64KB	Share
GSS	Investor presentation		07/09/22	4.49MB	Share
GSS	Full Year Statutory Accounts	PRICE SENSITIVE	31/08/22	934.21KB	Share
GSS	Quarterly update and Appendix 4C	PRICE SENSITIVE	27/07/22	261.35KB	Share
GSS	Clinical trial recruitment completed for US enteric kit	PRICE SENSITIVE	26/07/22	132.9KB	Share
GSS	Notification of cessation of securities - GSS		13/05/22	22.1KB	Share
GSS	Application for quotation of securities - GSS		13/05/22	28.87KB	Share
GSS	Initial Director's Interest Notice		13/05/22	208.46KB	Share
GSS	Director Appointment		13/05/22	129.65KB	Share
GSS	Notification of cessation of securities - GSS		03/05/22	21.58KB	Share
GSS	Application for quotation of securities - GSS		03/05/22	27.64KB	Share
GSS	Investor presentation		27/04/22	1.63MB	Share
GSS	Quarterly update and Appendix 4C	PRICE SENSITIVE	26/04/22	225.05KB	Share
GSS	Application for quotation of securities - GSS		12/04/22	25.12KB	Share
GSS	Public Health Wales Awards Enteric Testing Contract to GSS	PRICE SENSITIVE	30/03/22	140.27KB	Share
GSS	S&P DJI Announces March 2022 Quarterly Rebalance	PRICE SENSITIVE	04/03/22	175.5KB	Share
GSS	Company presentation		18/02/22	1.37MB	Share
GSS	Half Yearly Report and Accounts	PRICE SENSITIVE	18/02/22	655.82KB	Share
GSS	Investor webinar presentation		17/02/22	128.64KB	Share
GSS	Application for quotation of securities - GSS		01/02/22	28.85KB	Share
GSS	Investor presentation		28/01/22	1.58MB	Share
GSS	Quarterly update and Appendix 4C	PRICE SENSITIVE	21/01/22	228.34KB	Share
GSS	Application for quotation of securities - GSS		20/01/22	25.11KB	Share
GSS	3base SARS-CoV-2 kit registered by TGA for saliva samples	PRICE SENSITIVE	10/01/22	130.12KB	Share
GSS	Investor update	PRICE SENSITIVE	21/12/21	184.04KB	Share

GSS Final Director's Interest Notice
30/04/24		220.2KB	Share
GSS Leadership Transition at Genetic Signatures
30/04/24	PRICE SENSITIVE	572.05KB	Share
GSS Quarterly Activities/Appendix 4C Cash Flow Report
26/04/24	PRICE SENSITIVE	336.36KB	Share
GSS TGA authorises supply of updated Respiratory Detection Kit
22/04/24	PRICE SENSITIVE	393.22KB	Share
GSS Becoming a substantial holder
12/03/24		88.12KB	Share
GSS Change of Director's Interest Notice
29/02/24		221.02KB	Share
GSS 1H 24 Market Update
22/02/24	PRICE SENSITIVE	1.96MB	Share
GSS Half Yearly Report and Accounts
22/02/24	PRICE SENSITIVE	624KB	Share
GSS Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	340.82KB	Share
GSS Change in substantial holding
29/01/24		135.89KB	Share
GSS Change of Director's Interest Notice - S Chatonsky
25/01/24		221.4KB	Share
GSS Change of Director's Interest Notice - C Waldron
25/01/24		220.68KB	Share
GSS Change of Director's Interest Notice - T Radford
25/01/24		220.84KB	Share
GSS Change of Director's Interest Notice - J Melki
25/01/24		220.89KB	Share
GSS Change of Director's Interest Notice - N Samaras
25/01/24		225.71KB	Share
GSS Application for quotation of securities - GSS
25/01/24		24.53KB	Share
GSS Successful completion of underwritten rights issue
24/01/24		416.29KB	Share
GSS Change in substantial holding
22/01/24		139.58KB	Share
GSS Change in substantial holding
03/01/24		688.78KB	Share
GSS Change in substantial holding
03/01/24		3.26MB	Share
GSS Change in substantial holding
02/01/24		212.97KB	Share
GSS Rights Issue - Additional Payment Option For NZ Shareholders
02/01/24		206.25KB	Share
GSS Rights Issue - Notification to Ineligible Shareholders
02/01/24		679.52KB	Share
GSS Genetic Signatures Rights Issue Offer Booklet
02/01/24	PRICE SENSITIVE	6.48MB	Share
GSS Change of Director's Interest Notice
29/12/23		227.6KB	Share
GSS Notification of cessation of securities - GSS
29/12/23		21.6KB	Share
GSS Notification regarding unquoted securities - GSS
29/12/23		25.64KB	Share
GSS Cleansing Notice
29/12/23		265.5KB	Share
GSS Application for quotation of securities - GSS
29/12/23		24.88KB	Share
GSS Genetic Signatures Successfully Completes Placement
29/12/23	PRICE SENSITIVE	390.16KB	Share
GSS Cleansing Notice
21/12/23		576.15KB	Share
GSS Proposed issue of securities - GSS
21/12/23		38.11KB	Share
GSS Capital Raising Presentation
21/12/23	PRICE SENSITIVE	3.97MB	Share
GSS Genetic Signatures Announces $15.9m Capital Raising
21/12/23	PRICE SENSITIVE	919.66KB	Share
GSS $6.9m R&D tax incentive received
19/12/23	PRICE SENSITIVE	205.32KB	Share
GSS Trading Halt
19/12/23	PRICE SENSITIVE	221.87KB	Share
GSS Initial Director's Interest Notice
04/12/23		190.68KB	Share
GSS Genetic Signatures Appoints Non-Executive Director
04/12/23		347.88KB	Share
GSS AGM Results of Meeting
29/11/23		75.63KB	Share
GSS 2023 AGM Chairman's Address and CEO Presentation
29/11/23	PRICE SENSITIVE	2.72MB	Share
GSS Quarterly update and Appendix 4C
30/10/23	PRICE SENSITIVE	341.45KB	Share
GSS 2023 Notice of Annual General Meeting/Proxy Form
27/10/23		2.9MB	Share
GSS Investor Presentation - US Commercial Launch
19/09/23		8.04MB	Share
GSS Change in substantial holding
15/09/23		882.67KB	Share
GSS Investor Webinar - FY2023 Results and US FDA 510(k)
04/09/23		168.29KB	Share
GSS 510(k) Filing in Preparation for US Commercial Launch
04/09/23	PRICE SENSITIVE	2.52MB	Share
GSS FDA 510(k) for Gastrointestinal Parasite Kit Submitted
04/09/23	PRICE SENSITIVE	231.67KB	Share
GSS Appendix 4G and Corporate Governance Statement
31/08/23		483.66KB	Share
GSS Appendix 4E and Annual Report
31/08/23	PRICE SENSITIVE	4.19MB	Share
GSS Influenza B Detection Expected to Impact on Quarter Sales
25/08/23	PRICE SENSITIVE	284.96KB	Share
GSS Quarterly update and Appendix 4C
31/07/23	PRICE SENSITIVE	345.68KB	Share
GSS CFO/Company Secretary Appointment
16/06/23		52.78KB	Share
GSS Quarterly update and Appendix 4C
28/04/23	PRICE SENSITIVE	1.16MB	Share
GSS Company Secretary/CFO Appointment/Resignation
21/03/23		130.9KB	Share
GSS Investor Presentation
14/03/23		3.07MB	Share
GSS Change of Director's Interest Notice
01/03/23		263.79KB	Share
GSS Half Yearly Report and Accounts
22/02/23	PRICE SENSITIVE	1.36MB	Share
GSS Investor presentation
02/02/23		2.37MB	Share
GSS Quarterly update and Appendix 4C
30/01/23	PRICE SENSITIVE	286.28KB	Share
GSS Notification of cessation of securities - GSS
11/01/23		22.11KB	Share
GSS Investor webinar presentation
09/12/22		3.43MB	Share
GSS Change of Director's Interest Notice
18/11/22		260.76KB	Share
GSS Notification regarding unquoted securities - GSS
18/11/22		25.09KB	Share
GSS Results of Meeting
16/11/22		177.49KB	Share
GSS Chairman's Address to Shareholders & CEO Presentation
16/11/22		3.86MB	Share
GSS Change of Registry Address
31/10/22		77.61KB	Share
GSS Notification regarding unquoted securities - GSS
27/10/22		27.74KB	Share
GSS Notification of cessation of securities - GSS
27/10/22		21.59KB	Share
GSS Application for quotation of securities - GSS
27/10/22		24.83KB	Share
GSS Quarterly update and Appendix 4C
27/10/22	PRICE SENSITIVE	250.52KB	Share
GSS Investor presentation
18/10/22		5.59MB	Share
GSS Notice of Annual General Meeting/Proxy Form
14/10/22		475.48KB	Share
GSS Response to ASX Query
03/10/22	PRICE SENSITIVE	505.94KB	Share
GSS Appendix 4G and Corporate Governance Statement
30/09/22		592.67KB	Share
GSS Annual Report to shareholders
30/09/22		4.39MB	Share
GSS 3base Kit for Antimicrobial Resistance Shows High Detection
29/09/22	PRICE SENSITIVE	132.64KB	Share
GSS Investor presentation
07/09/22		4.49MB	Share
GSS Full Year Statutory Accounts
31/08/22	PRICE SENSITIVE	934.21KB	Share
GSS Quarterly update and Appendix 4C
27/07/22	PRICE SENSITIVE	261.35KB	Share
GSS Clinical trial recruitment completed for US enteric kit
26/07/22	PRICE SENSITIVE	132.9KB	Share
GSS Notification of cessation of securities - GSS
13/05/22		22.1KB	Share
GSS Application for quotation of securities - GSS
13/05/22		28.87KB	Share
GSS Initial Director's Interest Notice
13/05/22		208.46KB	Share
GSS Director Appointment
13/05/22		129.65KB	Share
GSS Notification of cessation of securities - GSS
03/05/22		21.58KB	Share
GSS Application for quotation of securities - GSS
03/05/22		27.64KB	Share
GSS Investor presentation
27/04/22		1.63MB	Share
GSS Quarterly update and Appendix 4C
26/04/22	PRICE SENSITIVE	225.05KB	Share
GSS Application for quotation of securities - GSS
12/04/22		25.12KB	Share
GSS Public Health Wales Awards Enteric Testing Contract to GSS
30/03/22	PRICE SENSITIVE	140.27KB	Share
GSS S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22	PRICE SENSITIVE	175.5KB	Share
GSS Company presentation
18/02/22		1.37MB	Share
GSS Half Yearly Report and Accounts
18/02/22	PRICE SENSITIVE	655.82KB	Share
GSS Investor webinar presentation
17/02/22		128.64KB	Share
GSS Application for quotation of securities - GSS
01/02/22		28.85KB	Share
GSS Investor presentation
28/01/22		1.58MB	Share
GSS Quarterly update and Appendix 4C
21/01/22	PRICE SENSITIVE	228.34KB	Share
GSS Application for quotation of securities - GSS
20/01/22		25.11KB	Share
GSS 3base SARS-CoV-2 kit registered by TGA for saliva samples
10/01/22	PRICE SENSITIVE	130.12KB	Share
GSS Investor update
21/12/21	PRICE SENSITIVE	184.04KB	Share

REFRESH

1 2 3 4

(20min delay)
Last 70.5¢		Change 0.005(0.71%)		Mkt cap ! $131.4M

Open	High	Low	Value	Volume
70.0¢	72.5¢	68.0¢	$63.98K	90.47K

Buyers (Bids)

No.	Vol.	Price($)
1	80	71.0¢

Sellers (Offers)

Price($)	Vol.	No.
72.5¢	5000	1

View Market Depth

No.	Vol.	Price($)
1	80	0.710
1	7773	0.700
1	1244	0.680
1	1539	0.650
1	1640	0.610

Price($)	Vol.	No.
0.725	5000	1
0.730	23422	1
0.740	3021	1
0.745	1343	1
0.750	25000	1

Last trade - 12.44pm 02/05/2024 (20 minute delay)

GSS (ASX) Chart

GENETIC SIGNATURES LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories